2024 annual financial data
Oruka Therapeutics 2024 Operating margin
Oruka Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -88,123,000 USD and net income was -83,724,000 USD.
Operating cash flow was -57,837,000 USD.
Get free Oruka Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -88,123,000 USD
- Net income
- -83,724,000 USD
- Operating cash flow
- -57,837,000 USD